Skip to main content

Advertisement

Log in

Is inferior vena caval filter an alternative treatment option for geriatric patients that cannot use anticoagulation therapy?

  • Case Report
  • Published:
Aging Clinical and Experimental Research Aims and scope Submit manuscript

Abstract

The incidence of deep vein thrombosis (DVT) and pulmonary embolism has been increasing in the elderly because of hypercoagulability associated with aging. Age has also been identified as an independent risk factor for bleeding complications related to anticoagulation therapy. Inferior vena cava filters could be used as alternatives to anticoagulant therapy for the prevention of pulmonary embolism when anticoagulation is either contraindicated or ineffective. Here, we report two geriatric patients who had documented acute DVT and in whom inferior vena caval filter was used because of the patients have a contraindication to use an anticoagulation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Koster T, Rosendaal FR, Reitsma PH, van der Velden PA, Briet E, Vandenbroucke JP (1994) Factor VII and fibrinogen levels as risk factors for venous thrombosis: a case-control study of plasma levels and DNA polymorphisms-the Leiden Thrombophilia Study (LETS). Thromb Haemost 71:719–722

    CAS  PubMed  Google Scholar 

  2. Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR (1995) Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 345:152–155

    Article  CAS  PubMed  Google Scholar 

  3. Meijers JC, Tekelenburg WL, Bouma BN, Bertina RM, Rosendaal FR (2000) High levels of coagulation factor XI as a risk factor for venous thrombosis. N Engl J Med 342:696–701

    Article  CAS  PubMed  Google Scholar 

  4. Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Tracy RP, Aleksic N, Folsom AR (2002) Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). Am J Med 113:636–642

    Article  PubMed  Google Scholar 

  5. Mari D, Coppola R, Provenzano R (2008) Hemostasis factors and aging. Exp Gerontol 43:66–73

    Article  CAS  PubMed  Google Scholar 

  6. Bauer KA (2000) Venous thromboembolism in malignancy. J Clin Oncol 18(17):3065–3067

    CAS  PubMed  Google Scholar 

  7. Greenfield LJ, Cho KJ, Protor MC, Sobel M, Shah S, Wingo J (1992) Late results of suprarenal Greenfield vena cava filter placement. Arch Surg 127:969–973

    Article  CAS  PubMed  Google Scholar 

  8. Stein PD, Kayali F, Olson RE (2004) Twenty-one-year trends in the use of inferior vena cava filters. Arch Intern Med 164(14):1541–1545

    Article  PubMed  Google Scholar 

  9. Tinetti ME, Speechley M, Ginter SF (1988) Riskfactors for falls among elderly persons living in the community. N Engl J Med 319:1701–1707

    Article  CAS  PubMed  Google Scholar 

  10. Nevitt MC, Cummings SR, Kidd S, Black D (1989) Risk factors for recurrent nonsyncopal falls: a prospective study. JAMA 261:2663–2668

    Article  CAS  PubMed  Google Scholar 

  11. Tinetti ME, Doucette J, Claus E, Marottoli RA (1995) Risk factors for serious injury during falls by older persons in the community. J Am Geriatr Soc 43:1214–1221

    CAS  PubMed  Google Scholar 

  12. Tarsy Daniel (2012) Treatment of Parkinson disease: A 64-year-old man with motor complications of advanced Parkinson disease. JAMA 307(21):2305–2314

    Article  CAS  PubMed  Google Scholar 

  13. Sithinamsuwan P, Orrawanhanothai P, Thithum K et al (2010) Orthostatic hypotension: a non-motor complication assessment in 82 patients with idiopathic Parkinson’s disease in Phramongkutklao Hospital. J Med Assoc Thai 93:93–99

    Google Scholar 

  14. Gattellari M, Worthington J, Zwar N et al (2008) Barriers to the use of anticoagulation for nonvalvular atrial fibrillation: a representative survey of Australian family physicians. Stroke 39:227–230

    Article  PubMed  Google Scholar 

  15. Rickles FR, Falanga A (2001) Molecular basis for the relationship between thrombosis and cancer. Thromb Res 102:215–224

    Article  Google Scholar 

  16. Decousus H, Leizorovicz A, Parent F et al (1998) A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N Engl J Med 338:409–415

    Article  CAS  PubMed  Google Scholar 

  17. Streiff MB (2003) Vena caval filters: a review for intensive care specialists. J Intensive Care Med 18:59–79

    Article  PubMed  Google Scholar 

  18. Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ (2008) American College of Chest Physicians, Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 133:454–545

    Article  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sibel Akın.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Akın, S., Sari, M., Tufan, F. et al. Is inferior vena caval filter an alternative treatment option for geriatric patients that cannot use anticoagulation therapy?. Aging Clin Exp Res 26, 73–75 (2014). https://doi.org/10.1007/s40520-013-0123-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40520-013-0123-9

Keywords

Navigation